Switch to:
More From Other Websites
XOMA Shoots up on Immuno-Oncology Deal with Novartis Oct 02 2015
3:51 am Novartis unit Sandoz receives FDA submission acceptance for its proposed biosimilar... Oct 02 2015
Novartis biosimilar copycat takes aim at Amgen's drug Enbrel Oct 02 2015
Working in-house becomes an exciting option for lawyers Oct 01 2015
Law firms implement tactics to level the playing field Oct 01 2015
Novartis Announces Positive Data on Arthritis Drug Cosentyx Oct 01 2015
Xoma enters exclusive license agreement with Novartis Oct 01 2015
Novartis announces NEJM publication of secukinumab Phase III data confirming significant efficacy in... Sep 30 2015
GlaxoSmithKline Pharmaceuticals completes transaction with Novartis Sep 30 2015
Novartis CEO: Here's How We'll Get Cheap Medicine To Poor Countries Sep 30 2015
Delta Air Lines, Tribune Publishing, Aduro BioTech, Incyte and Novartis highlighted as Zacks Bull... Sep 28 2015
Novartis drug Afinitor® significantly improves progression-free survival in advanced nonfunctional... Sep 26 2015
In A First, Kidney Cancer Drug Extends Survival Sep 26 2015
Bristol-Myers Kidney Cancer Drug Boosts Survival in Big Study Sep 25 2015
Novartis' new heart drug on track for approval in Europe Sep 25 2015
Novartis' new heart failure medicine Entresto(TM) recommended by CHMP for EU approval Sep 25 2015
Pharmaceuticals: Value over volume Sep 24 2015
Novartis appoints James E. Bradner, MD as President of the Novartis Institutes for BioMedical... Sep 24 2015
What You Should Know about the T. Rowe Price European Stock Fund Sep 24 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership